Anti-TACSTD2 monoclonal antibody

Pre-made anti-TACSTD2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TACSTD2/TACSTD2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0030-Ab-1/ GM-Tg-hg-IP0030-Ab-2Anti-Human TACSTD2 monoclonal antibodyHuman
GM-Tg-rg-IP0030-Ab-1/ GM-Tg-rg-IP0030-Ab-2Anti-Rat TACSTD2 monoclonal antibodyRat
GM-Tg-mg-IP0030-Ab-1/ GM-Tg-mg-IP0030-Ab-2Anti-Mouse TACSTD2 monoclonal antibodyMouse
GM-Tg-cynog-IP0030-Ab-1/ GM-Tg-cynog-IP0030-Ab-2Anti-Cynomolgus/ Rhesus macaque TACSTD2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0030-Ab-1/ GM-Tg-felg-IP0030-Ab-2Anti-Feline TACSTD2 monoclonal antibodyFeline
GM-Tg-cang-IP0030-Ab-1/ GM-Tg-cang-IP0030-Ab-2Anti-Canine TACSTD2 monoclonal antibodyCanine
GM-Tg-bovg-IP0030-Ab-1/ GM-Tg-bovg-IP0030-Ab-2Anti-Bovine TACSTD2 monoclonal antibodyBovine
GM-Tg-equg-IP0030-Ab-1/ GM-Tg-equg-IP0030-Ab-2Anti-Equine TACSTD2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0030-Ab-1/ GM-Tg-hg-IP0030-Ab-2; GM-Tg-rg-IP0030-Ab-1/ GM-Tg-rg-IP0030-Ab-2;
GM-Tg-mg-IP0030-Ab-1/ GM-Tg-mg-IP0030-Ab-2; GM-Tg-cynog-IP0030-Ab-1/ GM-Tg-cynog-IP0030-Ab-2;
GM-Tg-felg-IP0030-Ab-1/ GM-Tg-felg-IP0030-Ab-2; GM-Tg-cang-IP0030-Ab-1/ GM-Tg-cang-IP0030-Ab-2;
GM-Tg-bovg-IP0030-Ab-1/ GM-Tg-bovg-IP0030-Ab-2; GM-Tg-equg-IP0030-Ab-1/ GM-Tg-equg-IP0030-Ab-2
Products NameAnti-TACSTD2 monoclonal antibody
Formatmab
Target NameTACSTD2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TACSTD2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-983Pre-Made Sacituzumab Govitecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-ab-503Pre-Made Sacituzumab biosimilar, Whole mAb ADC, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody
    BiosimilarGMP-Bios-ab-134Pre-Made Datopotamab biosimilar, Whole mAb, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody
    BiosimilarGMP-Bios-INN-796Pre-Made Datopotamab Deruxtecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugate
    Target AntigenGM-Tg-g-IP0030-Ag-1Recombinant multi-species TACD2/ TACSTD2/ EGP-1 protein
    ORF Viral VectorpGMLP002819human TACSTD2 Lentivirus plasmid
    ORF Viral VectorvGMLP002819human TACSTD2 Lentivirus particle
    ORF Viral VectorpGMLPm000454mouse Tacstd2 Lentivirus plasmid
    ORF Viral VectorvGMLPm000454mouse Tacstd2 Lentivirus particle


    Target information

    Target IDGM-IP0030
    Target NameTACSTD2
    Gene ID4070,56753,494343,716334,610286,101097004,539853,100067576
    Gene Symbol and SynonymsEGP-1,EGP1,GA733-1,GA7331,GP50,Ly97,M1S1,Prp1,TACSTD2,TROP2
    Uniprot AccessionP09758,Q6P9Z6
    Uniprot Entry NameTACD2_HUMAN,TACD2_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000184292
    Target ClassificationCheckpoint-Immuno Oncology

    The target: TACSTD2, gene name: TACSTD2, also named as EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1, TROP2. This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.[provided by RefSeq, Dec 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.